Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?1.84
 
WKN: A3DZ7F / Symbol: KPRX / Name: Kiora Pharmaceuticals / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Kiora Pharmaceuticals Inc. Stock

With 6 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 1 € there is potential for a 138.95% increase which would mean more than doubling the current price of 0.42 € for Kiora Pharmaceuticals Inc..
Our community identified positive and negative aspects for Kiora Pharmaceuticals Inc. stock for the coming years. 1 users see the criterium "Brand" as a plus for the Kiora Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Kiora Pharmaceuticals Inc. in the next few years

Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) was upgraded by analysts at Maxim Group to a "strong-buy" rating.
Ratings data for KPRX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -22.06%
Target price 1.841
Change
Ends at 20.05.25

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
Ratings data for KPRX provided by MarketBeat
Show more

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright.
Ratings data for KPRX provided by MarketBeat
Show more